Clinical Outsourcing to Latin America: First Movers See Strong Upside in Evolving Clinical Sector
July 4th, 2011
Special Report: Exploring the powerful business case for Nearshore BPO-supported clinical research
By Chris Nuttall and Silvio Klimovsky
Pharmaceutical and biotech companies spend over $20 billion per year outsourcing key elements of clinical development. Processes such as clinical trials management, data management, study statistics, site monitoring and associated IT make clinical outsourcing to Contract Research Organizations (CROs) and Business Process Outsourcing (BPO) service providers big business. Firms have outsourced transactional activities for many years and as the commercial and cost pressures on the life sciences industry continue to increase, so does the scale and pace of outsourcing.
Big Upside for Latin American CROs
September 15th, 2009Bright Future for CROs: Why Offshore Lab Research is Booming
By Federico L. O’Conor, founder, ICCL Inteligencia de Mercados.
Contract Research Organizations (CRO) in Latin America are key strategic partners to many pharmaceutical and 
biotech companies from North America and Europe. CRO’s allows these firms to concentrate efforts in their core skills, mostly related to manufacturing, marketing and sales. In the continuous race to optimize resources, cost reduction generally results the very first variable to be adjusted. Areas such as legal affairs and logistics have been pioneers when their specific duties have been outsourced into the hands of organizations more specialized in those key activities.
Beginning fifteen years ago, healthcare enterprises began using outsourcing providers to assist in areas like Regulatory Submissions, Patient Recruitment, Project Management and Clinical Monitoring. In recent years, Latin America has become an increasingly attractive destination.
First reports of …
